Literature DB >> 18564280

Changing a concept--controversy on the confusing spectrum of the reticulate pigmented disorders of the skin.

Cornelia S L Müller1, Claudia Pföhler, Wolfgang Tilgen.   

Abstract

Galli-Galli disease (GGD) and Dowling-Degos disease (DDD) are inherited skin diseases with variable progressive course. They are of benign and harmless behaviour but aesthetically annoying. They are subsumed within the group of reticulate pigmented disorders of the skin to which, additionally, Kitamura's and Haber's diseases are counted. Clinical appearance is approximately similar, with slight differences in age of onset and associated disorders. Histopathological features are almost similar aside from the unique hallmark of suprabasal acantholysis, which can exclusively be observed in GGD. We report four typical cases of reticulate pigmented disorders, clinically accordable to DDD but histopathologically allocated to GGD. In conclusion, we purpose the idea of a wide spectrum of reticulate pigmented disorders in which Morbus Galli-Galli should probably be reclassified as a subset of DDD.

Entities:  

Mesh:

Year:  2008        PMID: 18564280     DOI: 10.1111/j.1600-0560.2008.00995.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

1.  Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.

Authors:  Jennifer C Tang; Julia Escandon; Michael Shiman; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2012-05

2.  [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].

Authors:  S Hanneken; A Rütten; S Eigelshoven; M Braun-Falco; S M Pasternack; T Ruzicka; M M Nöthen; R C Betz; R Kruse
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

3.  [Hereditary pigmentary disorders].

Authors:  K Giehl; M Braun-Falco
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

4.  Galli-galli disease: a rare acantholytic variant of dowling-degos disease.

Authors:  J Gomes; J Labareda; I Viana
Journal:  Case Rep Med       Date:  2011-05-05

5.  Acitretin therapy for Galli-Galli disease.

Authors:  Chandler W Rundle; Solveig Ophaug; Eric L Simpson
Journal:  JAAD Case Rep       Date:  2020-04-30

6.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.